SCHEMBL17034973

SCHEMBL17034973

O=P(c1ccccc1)(c1ccccc1)c1cccc(-c2cc3c(-c4cccnc4)nc4ccccc4c3c3ccccc23)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.40
CYP2C9 P11712 5/20 0.40
DHODH Q02127 1/20 0.40
KCNA5 P22460 2/20 0.39
KCNN4 O15554 1/20 0.39
CYP19A1 P11511 1/20 0.39
RAD51 Q06609 1/20 0.39
F2 P00734 1/20 0.39
HPGD P15428 1/20 0.39
MEN1 O00255 2/20 0.37
LMNA P02545 2/20 0.37
KMT2A Q03164 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NPC1 O15118 1/20 0.37
THRB P10828 1/20 0.37
HTT P42858 1/20 0.37
RAB9A P51151 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MAPT P10636 2/20 0.37
TP53 P04637 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17034882 0.96 CYP11B1 (0.43) CYP11B1CYP2C9DHODHKCNA5KCNN4
SCHEMBL17034963 0.94 DHODH (0.43) CYP11B1CYP2C9DHODHKCNA5KCNN4
SCHEMBL17034970 0.90 DHODH (0.37) DHODHHPGDMEN1LMNAKMT2A
SCHEMBL17035027 0.89 DHODH (0.41) CYP11B1CYP2C9DHODHKCNA5KCNN4
SCHEMBL18201314 0.84 TOP1 (0.35) DHODHMEN1KMT2A
SCHEMBL17034980 0.84 DHODH (0.36) DHODHMEN1LMNAKMT2AL3MBTL1
SCHEMBL17034962 0.84 DHODH (0.49) CYP11B1CYP2C9DHODHCYP19A1RAD51
SCHEMBL18201313 0.83 PDGFRB (0.41) CLK4
SCHEMBL18200769 0.82 ADORA2A (0.34) CYP2C9DHODHMAPTALDH1A1
SCHEMBL17035025 0.82 DHODH (0.36) DHODHHPGDMEN1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243895-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243895-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 CYP11B1 781/4885CYP2C9 437/4885DHODH 2312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.